EGRX Eagle Pharmaceuticals, Inc. Stock Quote

EGRX [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	20.33	EPS (ttm)	1.77	Insider Own	12.40%	Shs Outstand	12.84M	Perf Week	-16.64%
Market Cap	455.82M	Forward P/E	11.71	EPS next Y	3.07	Insider Trans	0.00%	Shs Float	11.69M	Perf Month	-19.88%
Income	22.80M	PEG	7.53	EPS next Q	0.93	Inst Own	85.70%	Short Float	8.62%	Perf Quarter	-18.36%
Sales	272.20M	P/S	1.67	EPS this Y	-175.90%	Inst Trans	-0.62%	Short Ratio	7.11	Perf Half Y	-26.00%
Book/sh	18.54	P/B	1.94	EPS next Y	-56.94%	ROA	7.50%	Target Price	45.50	Perf Year	-26.35%
Cash/sh	2.88	P/C	12.45	EPS next 5Y	2.70%	ROE	11.20%	52W Range	33.72 - 58.25	Perf YTD	-29.46%
Dividend	-	P/FCF	12.91	EPS past 5Y	-16.40%	ROI	-0.60%	52W High	-38.33%	Beta	0.60
Dividend %	-	Quick Ratio	1.30	Sales past 5Y	-2.00%	Gross Margin	73.60%	52W Low	6.54%	ATR	2.08
Employees	102	Current Ratio	1.80	Sales Q/Q	54.10%	Oper. Margin	21.20%	RSI (14)	34.55	Volatility	9.22% 5.45%
Optionable	Yes	Debt/Eq	0.21	EPS Q/Q	-370.30%	Profit Margin	8.40%	Rel Volume	1.19	Prev Close	35.79
Shortable	Yes	LT Debt/Eq	0.12	Earnings	Aug 09 BMO	Payout	0.00%	Avg Volume	141.76K	Price	35.92
Recom	2.30	SMA20	-11.12%	SMA50	-16.23%	SMA200	-23.76%	Volume	169,213	Change	0.36%

Apr-07-21

Resumed

RBC Capital Mkts

Outperform

$52

Nov-01-18

Downgrade

Cantor Fitzgerald

Overweight → Neutral

Oct-31-18

Downgrade

Piper Jaffray

Overweight → Neutral

Mar-21-18

Reiterated

Mizuho

Underperform

$37 → $40

Nov-09-17

Reiterated

RBC Capital Mkts

Outperform

$81 → $75

Sep-06-17

Reiterated

Mizuho

Underperform

$40 → $37

Jul-27-17

Reiterated

RBC Capital Mkts

Outperform

$94 → $81

Jul-27-17

Reiterated

Mizuho

Underperform

$57 → $40

May-09-17

Reiterated

RBC Capital Mkts

Outperform

$86 → $94

Jan-09-17

Downgrade

Mizuho

Neutral → Underperform

$78 → $64

Nov-16-16

Downgrade

Mizuho

Buy → Neutral

$78

Nov-03-16

Upgrade

Mizuho

Neutral → Buy

$62 → $78

Nov-03-16

Reiterated

RBC Capital Mkts

Outperform

$80 → $93

Oct-26-16

Reiterated

Mizuho

Buy

$65 → $62

Aug-16-16

Reiterated

Mizuho

Neutral

$47 → $65

Jun-20-16

Downgrade

Mizuho

Buy → Neutral

$66 → $47

May-10-16

Reiterated

RBC Capital Mkts

Outperform

$94 → $78

Mar-18-16

Reiterated

Mizuho

Buy

$81 → $71

Feb-26-16

Reiterated

Mizuho

Buy

$112 → $81

Dec-09-15

Initiated

Mizuho

Buy

$112

Aug-15-22 06:20AM	Time To Worry? Analysts Are Downgrading Their Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Outlook Simply Wall St.
Aug-09-22 12:00PM	Eagle Pharmaceuticals (EGRX) Q2 2022 Earnings Call Transcript Motley Fool -14.46%
08:51AM	Eagle Pharma Broadens Acute Care Portfolio With Equity Stake In Respiratory Depression Player Benzinga
08:15AM	Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Lag Estimates Zacks
06:50AM	Eagle Pharmaceuticals Reports Second Quarter 2022 Results GlobeNewswire
06:45AM	Eagle Pharmaceuticals Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics to Advance Global Development of ENA-001, a Novel Agnostic Respiratory Stimulant GlobeNewswire
Aug-08-22 11:33AM	Is Eagle Pharmaceuticals (NASDAQ:EGRX) A Risky Investment? Simply Wall St.
Jul-28-22 04:05PM	Eagle Pharmaceuticals to Host Second Quarter 2022 Financial Results on August 9, 2022 GlobeNewswire
Jul-27-22 10:32AM	TEVA Beats on Q2 Earnings, to Settle Opioid Lawsuit for $4.3B Zacks
Jul-18-22 06:50AM	Eagle Pharmaceuticals Appoints Debra M. Hussain as SVP, Head of Commercial GlobeNewswire
Jun-13-22 11:12AM	Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? Simply Wall St.
Jun-09-22 07:30AM	Eagle Pharmaceuticals Completes Acquisition of Acacia Pharma Group plc, Expanding Acute Care Footprint GlobeNewswire
Jun-02-22 11:31AM	Zacks.com featured highlights include Eagle Pharmaceuticals, Cabot, Meritage Homes, Griffon, and APA Zacks
Jun-01-22 07:26AM	Press the Buy Button on These 5 High Earnings Yield Picks Now Zacks
06:50AM	Eagle Pharmaceuticals Announces Submission of New Drug Application to U.S. Food and Drug Administration for Landiolol, a Beta-1 Adrenergic Blocker GlobeNewswire
May-26-22 06:50AM	Eagle Pharmaceuticals to Present at the William Blair 42nd Annual Growth Stock Conference GlobeNewswire
May-25-22 09:46AM	The past five years for Eagle Pharmaceuticals (NASDAQ:EGRX) investors has not been profitable Simply Wall St.
May-09-22 01:00PM	Eagle Pharmaceuticals (EGRX) Q1 2022 Earnings Call Transcript Motley Fool
08:25AM	Eagle Pharmaceuticals (EGRX) Q1 Earnings Top Estimates Zacks
06:50AM	Eagle Pharmaceuticals Reports First Quarter 2022 Results GlobeNewswire
May-07-22 09:12AM	Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Shares Could Be 28% Below Their Intrinsic Value Estimate Simply Wall St.
May-04-22 11:07AM	TEVA Matches Q1 Earnings Estimates, Lowers 2022 Sales View Zacks
Apr-28-22 04:30PM	Eagle Pharmaceuticals to Host First Quarter 2022 Financial Results on May 9, 2022 GlobeNewswire
Apr-19-22 06:50AM	Eagle Pharmaceuticals Reaches Settlement Agreement with Hospira Related to BENDEKA® (bendamustine hydrochloride) until January 17, 2028 GlobeNewswire
Apr-12-22 08:45AM	OrganiGram (OGI) Reports Q2 Loss, Tops Revenue Estimates Zacks
Mar-28-22 11:33AM	Eagle Pharma Adds Hospital-Based Products With 95M Acacia Pharma Deal Benzinga +8.26%
04:00AM	Eagle Pharmaceuticals Agrees to Terms to Acquire Acacia Pharma Group plc GlobeNewswire
Mar-15-22 09:40AM	Is Eagle Pharmaceuticals (EGRX) Stock Outpacing Its Medical Peers This Year? Zacks
Mar-07-22 12:30PM	Eagle Pharmaceuticals (EGRX) Q4 2021 Earnings Call Transcript Motley Fool +5.88%
08:05AM	Eagle Pharmaceuticals (EGRX) Lags Q4 Earnings and Revenue Estimates Zacks
06:50AM	Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results GlobeNewswire
Mar-01-22 08:38AM	Does Eagle Pharmaceuticals (NASDAQ:EGRX) Have A Healthy Balance Sheet? Simply Wall St. -5.00%
Feb-24-22 06:50AM	Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results on March 7, 2022 GlobeNewswire
Feb-10-22 11:43AM	TEVA Stock Up on Q4 Earnings Beat, Sales Miss Estimates Zacks
09:35AM	What's in the Cards for Henry Schein (HSIC) in Q4 Earnings? Zacks
Feb-01-22 06:50AM	Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY Business Wire
Jan-31-22 06:50AM	Eagle Pharmaceuticals on Track to Support Submission of New Drug Application in Second Quarter 2022 for Landiolol, a Beta-1 Adrenergic Blocker Business Wire
Jan-18-22 06:50AM	Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin Business Wire
Jan-12-22 11:20AM	Philips' (PHG) Q4 Earnings Hit By Supply-Chain Issues, Recall Zacks -7.02%
Jan-05-22 01:39PM	Eagle Pharmaceuticals Provides 2022 Business Update and Announces Launch of Vasopressin Business Wire
Jan-03-22 04:30PM	Eagle Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-29-21 11:24AM	Eagle Pharmaceuticals Receives 180 Days of Marketing Exclusivity for Recently Approved Vasopressin Business Wire
Dec-26-21 07:17AM	Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? Simply Wall St.
Dec-23-21 09:24AM	4 High Earnings Yield Stocks Likely to Pay Off Big Time Zacks
Dec-22-21 12:00PM	Eagle Pharmaceuticals (EGRX) Upgraded to Buy: Here's What You Should Know Zacks
Dec-20-21 11:39AM	Eagle Pharmaceuticals Reports that Par Has Unilaterally Withdrawn Attempt to Halt Launch of Vasopressin Business Wire
Dec-15-21 02:54PM	UPDATE 1-U.S. FDA approves Eagles generic version of Endo blood pressure drug Reuters +12.09%
01:54PM	Eagle Pharmaceuticals Receives FDA Approval for Vasopressin Business Wire
Nov-22-21 06:50AM	Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 Business Wire
Nov-11-21 06:18AM	Eagle Pharmaceuticals (NASDAQ:EGRX) investors are sitting on a loss of 32% if they invested five years ago Simply Wall St.
Nov-09-21 03:00PM	Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript Motley Fool
08:13AM	The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga
08:05AM	Eagle Pharmaceuticals (EGRX) Q3 Earnings and Revenues Lag Estimates Zacks
06:50AM	Eagle Pharmaceuticals Reports Third Quarter 2021 Results Business Wire
Oct-28-21 05:05PM	Eagle Pharmaceuticals to Host Third Quarter 2021 Financial Results on November 9, 2021 Business Wire
Oct-25-21 03:01PM	Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for Zacks
Sep-22-21 08:43AM	We Think Eagle Pharmaceuticals (NASDAQ:EGRX) Can Manage Its Debt With Ease Simply Wall St.
Sep-07-21 06:50AM	Reminder: Eagle Pharmaceuticals to Host CAL02 Investor Event on September 9, 2021 Business Wire
Sep-01-21 05:00PM	Eagle Pharmaceuticals to Present at September Healthcare Conferences Business Wire
09:41AM	Company News for Sep 1, 2021 Zacks
Aug-31-21 12:33PM	5 Top Stock Gainers for Tuesday: Virgin Galactic, Digital Turbine TheStreet.com +10.22%
12:05PM	33 Stocks Moving In Tuesday's Mid-Day Session Benzinga
11:45AM	Eagle Pharmaceuticals Wins Vasopressin Patent Trial Business Wire
06:50AM	Eagle Pharmaceuticals Granted Additional Patent for Bendamustine Franchise Business Wire
Aug-25-21 06:50AM	Eagle Pharmaceuticals Announces Worldwide Licensing Agreement with Combioxin SA for Phase 2b/3, Novel First-in-Class Antitoxin Agent CAL02 in Development for Combination Use with Antibiotics for the Treatment of Severe Pneumonia Business Wire
Aug-09-21 04:30PM	Eagle Pharmaceuticals, inc (EGRX) Q2 2021 Earnings Call Transcript Motley Fool
08:05AM	Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Surpass Estimates Zacks
06:50AM	Eagle Pharmaceuticals Reports Second Quarter 2021 Results Business Wire
06:45AM	Eagle Pharmaceuticals Announces Licensing Agreement with AOP Orphan for U.S. Commercial Rights to Landiolol, a Beta-1 Adrenergic Blocker Business Wire
Aug-02-21 03:01PM	Eagle Pharmaceuticals (EGRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jul-29-21 03:32PM	Were Hedge Funds Right About Eagle Pharmaceuticals Inc (EGRX)? Insider Monkey
Jul-28-21 04:30PM	Eagle Pharmaceuticals to Host Second Quarter 2021 Financial Results on August 9, 2021 Business Wire
Jul-14-21 02:28AM	Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? Simply Wall St.
Jun-24-21 06:50AM	Eagle Pharmaceuticals Announces FDA Maintains Prioritization of ANDA for Vasopressin Business Wire
Jun-18-21 10:47AM	New Strong Sell Stocks for June 18th Zacks
Jun-17-21 06:50AM	Eagle Pharmaceuticals Submits Response to Complete Response Letter from FDA for Vasopressin Business Wire
Jun-11-21 12:08PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Eagle Pharmaceuticals, Inc.- EGRX Newsfile
May-30-21 04:06AM	Would Shareholders Who Purchased Eagle Pharmaceuticals' (NASDAQ:EGRX) Stock Three Years Be Happy With The Share price Today? Simply Wall St.
May-26-21 05:00PM	Eagle Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021 Business Wire
May-14-21 05:54PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Eagle Pharmaceuticals, Inc.- EGRX Newsfile
May-11-21 05:00PM	Eagle Pharmaceuticals to Present at the 2021 RBC Capital Markets Global Healthcare Conference Business Wire
May-10-21 11:30AM	Eagle Pharmaceuticals Inc (EGRX) Q1 2021 Earnings Call Transcript Motley Fool -7.64%
08:05AM	Eagle Pharmaceuticals (EGRX) Q1 Earnings and Revenues Miss Estimates Zacks
06:50AM	Eagle Pharmaceuticals Reports First Quarter 2021 Results Business Wire
06:45AM	Eagle Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
06:45AM	Eagle Pharmaceuticals Announces Filing of TREAKISYM (bendamustine) Rapid Infusion ("RI") Liquid Formulation in Japan Business Wire
May-03-21 03:01PM	Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for Zacks
06:50AM	Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of Directors Business Wire
Apr-30-21 06:50AM	Eagle Pharmaceuticals Announces TREAKISYM (bendamustine) Ready-to-Dilute ("RTD") Formulation, in Combination with Rituximab for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma Receives PMDA Approval in Japan Business Wire
Apr-29-21 04:30PM	Eagle Pharmaceuticals to Host First Quarter 2021 Financial Results on May 10, 2021 Business Wire
07:05AM	TEVA Beats on Q1 Earnings and Sales, Keeps View, Stock Down Zacks
Apr-22-21 12:28PM	Heres Why Summers Value Partners Exited its Eagle Pharmaceuticals (EGRX) Position Insider Monkey
Apr-15-21 03:22AM	We Think Eagle Pharmaceuticals (NASDAQ:EGRX) Can Manage Its Debt With Ease Simply Wall St.
Mar-15-21 04:08PM	Top Pharmaceutical Stocks for Q2 2021 Investopedia
Mar-03-21 12:23AM	Is Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Trading At A 21% Discount? Simply Wall St.
Mar-02-21 02:00PM	Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript Motley Fool -10.97%
08:15AM	Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings Estimates Zacks
06:50AM	Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results and Provides Pipeline Review Business Wire
06:30AM	Eagle Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-21 10:15AM	Earnings Preview: Eagle Pharmaceuticals Benzinga

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience